Eric Powers to Heart Failure
This is a "connection" page, showing publications Eric Powers has written about Heart Failure.
Connection Strength
0.303
-
Relation of Lymphangiogenic Factor Vascular Endothelial Growth Factor-D to Elevated Pulmonary Artery Wedge Pressure. Am J Cardiol. 2019 09 01; 124(5):756-762.
Score: 0.086
-
The management of congestive heart failure. Compr Ther. 1996 May; 22(5):291-6.
Score: 0.069
-
Comparison of lipid deposition at coronary bifurcations versus at nonbifurcation portions of coronary arteries as determined by near-infrared spectroscopy. Am J Cardiol. 2013 Aug 01; 112(3):369-72.
Score: 0.056
-
The effect of captopril on renal, coronary, and systemic hemodynamics in patients with severe congestive heart failure. Am Heart J. 1982 Nov; 104(5 Pt 2):1203-10.
Score: 0.027
-
Why do patients with congestive heart failure tolerate the initiation of beta-blocker therapy? Circulation. 1993 Oct; 88(4 Pt 1):1610-9.
Score: 0.014
-
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. N Engl J Med. 1993 Jul 15; 329(3):149-55.
Score: 0.014
-
Bolus intravenous nitroglycerin predominantly reduces afterload in patients with excessive arterial elastance. J Am Coll Cardiol. 1993 Jul; 22(1):251-7.
Score: 0.014
-
Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group. J Am Coll Cardiol. 1989 May; 13(6):1240-7.
Score: 0.011
-
Reduced lymphocyte stimulatory guanine nucleotide regulatory protein and beta-adrenergic receptors in congestive heart failure and reversal with angiotensin converting enzyme inhibitor therapy. Circulation. 1988 Dec; 78(6):1373-9.
Score: 0.010